The ROE as of December 2024 (TTM) for Accuray Incorporated (ARAY) is -36.93%

According to Accuray Incorporated’s latest financial reports and current stock price. The company's current ROE is -36.93%. This represents a change of 300.78% compared to the average of -9.21% of the last 4 quarters.

Accuray Incorporated (ARAY) Historical ROE (quarterly & annually)

How has ARAY ROE performed in the past?

The mean historical ROE of Accuray Incorporated over the last ten years is -30.64%. The current -36.93% ROE has changed 20.54% with respect to the historical average. Over the past ten years (40 quarters), ARAY's ROE was at its highest in in the December 2019 quarter at 19.13%. The ROE was at its lowest in in the September 2019 quarter at -22.83%.

Accuray Incorporated (ARAY) ROE by Quarter and Year

Discovering the peaks and valleys of Accuray Incorporated ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Accuray Incorporated (ARAY) Average ROE

How has ARAY ROE performed in the past?

The current ROE of Accuray Incorporated (ARAY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Accuray Incorporated (ARAY) ROE vs. Peers

How is ARAY’s ROE compared to its peers?

Accuray Incorporated’s ROE is greater than Surmodics, Inc. (-9.56%), greater than AxoGen, Inc. (-14.91%), greater than Bioventus Inc. (-24.50%), less than Cutera, Inc. (63.25%), less than NuVasive, Inc. (4.86%), greater than Paragon 28, Inc. (-38.77%), greater than Orthofix Medical Inc. (-21.25%), greater than SI-BONE, Inc. (-22.51%), less than Avanos Medical, Inc. (1.28%), less than Aziyo Biologics, Inc. (124.47%), greater than Apyx Medical Corporation (-156.40%), less than INVO Bioscience, Inc. (0%), less than Artivion, Inc. (-0.29%), greater than Anika Therapeutics, Inc. (-48.10%), greater than Sight Sciences, Inc. (-47.28%), greater than Cytosorbents Corporation (-13069.04%), greater than NeuroPace, Inc. (-205.41%), greater than ClearPoint Neuro, Inc. (-62.10%), greater than TELA Bio, Inc. (-556.18%), greater than OrthoPediatrics Corp. (-7.64%),

Build a custom stock screener for Accuray Incorporated (ARAY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Accuray Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Accuray Incorporated (ARAY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Accuray Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.